salveco
Entry
2020
Hold
1yr
Exit
2021
Who owns salveco?
salveco was owned by Sobera Capital through Sobera Capital Fund V (2020 vintage) from 2020 to 2021, exited via Trade Sale.
Buyer identity available on Pro.
Hand-verified · updated 2026-08-10
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2021
More from Sobera Capital Fund V
Other portfolio companies in the same fund.
More Sobera Capital portfolio companies
From the same investor, across funds.
Axellis
Exited 2022
MedTech
United Kingdom· 2018
EffRx Pharmaceuticals
Exited 2023
Pharma
Switzerland· 2018
to
M.O.R.E Medical Solutions
Active
MedTech
Germany· 2018
Memo Therapeutics
Exited 2026
Biotech
Switzerland· 2018
to
MyoScience
Exited 2019
MedTech
United States· 2018
to
Presidio Pharmaceuticals
Active
Pharma
United States· 2018
More PE-backed in Consumer
Comparable consumer deals from other GPs.
Track salveco
Save this record to your watchlist and pick up your research where you left off. No spam.
Get the full record on salveco.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue